Shannon Zhang

843 total citations
20 papers, 575 citations indexed

About

Shannon Zhang is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Cancer Research. According to data from OpenAlex, Shannon Zhang has authored 20 papers receiving a total of 575 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Cancer Research. Recurrent topics in Shannon Zhang's work include Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Shannon Zhang is often cited by papers focused on Lung Cancer Treatments and Mutations (14 papers), Lung Cancer Research Studies (3 papers) and Lung Cancer Diagnosis and Treatment (3 papers). Shannon Zhang collaborates with scholars based in United States, Japan and Singapore. Shannon Zhang's co-authors include Misako Nagasaka, Sai‐Hong Ignatius Ou, Viola W. Zhu, Shiyin Yao, Tomoko Hayashi, Dennis A. Carson, Cristiana Guiducci, Tadashi Hosoya, Ryuji Suzuki and Minya Pu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Bioconjugate Chemistry and BMC Cancer.

In The Last Decade

Shannon Zhang

20 papers receiving 561 citations

Peers

Countries citing papers authored by Shannon Zhang

Since Specialization

Citations

This map shows the geographic impact of Shannon Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shannon Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shannon Zhang more than expected).

Fields of papers citing papers by Shannon Zhang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shannon Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shannon Zhang. The network helps show where Shannon Zhang may publish in the future.

Co-authorship network of co-authors of Shannon Zhang

This figure shows the co-authorship network connecting the top 25 collaborators of Shannon Zhang. A scholar is included among the top collaborators of Shannon Zhang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shannon Zhang. Shannon Zhang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CodeBreak 200: Sotorasib Has Not Broken the KRASG12C Enigma Code 2023 ·PubMed ·Shannon Zhang, (unknown), Misako Nagasaka	7
2	Low-Dose Computed Tomography (LDCT) Lung Cancer Screening in Asian Female Never-Smokers Is as Efficacious in Detecting Lung Cancer as in Asian Male Ever-Smokers: A Systematic Review and Meta-Analysis 2023 ·Journal of Thoracic Oncology ·(unknown), Shannon Zhang, Misako Nagasaka, (unknown), Joseph J. Zhao, Nicholas Syn, Takaomi Hanaoka, Sai‐Hong Ignatius Ou, Elaine Shum	22
3	Pan-tumor survey of ROS1 fusions detected by next-generation RNA and whole transcriptome sequencing 2023 ·BMC Cancer ·Misako Nagasaka, Shannon Zhang, Yasmine Baca, Joanne Xiu, Jorge J. Nieva, Ari M. Vanderwalde, Jeffrey Swensen, David Spetzler, W. Michael Korn, Luis E. Raez, Stephen V. Liu, Sai‐Hong Ignatius Ou	7
4	Lorlatinib Tolerability and Association With Clinical Outcomes in Patients With Advanced ALK- or ROS1-Rearranged NSCLC: A Brief Report 2023 ·JTO Clinical and Research Reports ·Rohit Thummalapalli, Noura J. Choudhury, (unknown), (unknown), (unknown), Shannon Zhang, (unknown), Monica F. Chen, Glenn Heller, Suresh S. Ramalingam, Sai‐Hong Ignatius Ou, Kathryn F. Mileham, Gregory J. Riely	1
5	Comprehensive Review of ROS1 Tyrosine Kinase Inhibitors-Classified by Structural Designs and Mutation Spectrum (Solvent Front Mutation [G2032R] and Central β-Sheet 6 [Cβ6] Mutation [L2086F]) 2023 ·Journal of Thoracic Oncology ·Sai‐Hong Ignatius Ou, (unknown), Shannon Zhang, Misako Nagasaka	16
6	Spotlight on Tepotinib and Capmatinib for Non-Small Cell Lung Cancer with MET Exon 14 Skipping Mutation 2022 ·PubMed ·(unknown), Shannon Zhang, Misako Nagasaka	16
7	Amivantamab (JNJ-61186372) induces clinical, biochemical, molecular, and radiographic response in a treatment-refractory NSCLC patient harboring amplified triple EGFR mutations (L858R/ T790M/G796S) in cis 2022 ·Lung Cancer ·Misako Nagasaka, Ani Sarkis Balmanoukian, Russell W. Madison, Shannon Zhang, Samuel J. Klempner, Sai‐Hong Ignatius Ou	11
8	A High Percentage of NSCLC With Germline CHEK2 Mutation Harbors Actionable Driver Alterations: Survey of a Cancer Genomic Database and Review of Literature 2022 ·JTO Clinical and Research Reports ·Shannon Zhang, Jessica Lee, Hanna Tukachinsky, Alexa B. Schrock, Misako Nagasaka, Sai‐Hong Ignatius Ou	1
9	Deconstructing ADAURA: It is Time to Forgo Adjuvant Platinum-Based Chemotherapy in Resected IB-IIIA EGFR+ NSCLC (Except with RB Alterations?) When Adopting Adjuvant Osimertinib 2022 ·SHILAP Revista de lepidopterología ·Shannon Zhang, Sai‐Hong Ignatius Ou	4
10	Spotlight on Furmonertinib (Alflutinib, AST2818). The Swiss Army Knife (del19, L858R, T790M, Exon 20 Insertions, “uncommon-G719X, S768I, L861Q”) Among the Third-Generation EGFR TKIs? 2022 ·PubMed ·Shannon Zhang, Sai‐Hong Ignatius Ou	16
11	Thromboembolism in ALK+ and ROS1+ NSCLC patients: A systematic review and meta-analysis 2021 ·Lung Cancer ·Viola W. Zhu, Joseph J. Zhao, (unknown), Nicholas Syn, Shannon Zhang, Sai‐Hong Ignatius Ou, Kenneth A. Bauer, Misako Nagasaka	33
12	Spotlight on Sotorasib (AMG 510) for KRASG12C Positive Non-Small Cell Lung Cancer 2021 ·SHILAP Revista de lepidopterología ·Shannon Zhang, Misako Nagasaka	32
13	Going beneath the tip of the iceberg. Identifying and understanding EML4-ALK variants and TP53 mutations to optimize treatment of ALK fusion positive (ALK+) NSCLC 2021 ·Lung Cancer ·Shannon Zhang, Misako Nagasaka, Viola W. Zhu, Sai‐Hong Ignatius Ou	74
14	Spotlight on Mobocertinib (TAK-788) in NSCLC with EGFR Exon 20 Insertion Mutations 2021 ·SHILAP Revista de lepidopterología ·Shannon Zhang, Viola W. Zhu	15
15	Identification of Novel CDH1-NRG2α and F11R-NRG2α Fusions in NSCLC Plus Additional Novel NRG2α Fusions in Other Solid Tumors by Whole Transcriptome Sequencing 2020 ·JTO Clinical and Research Reports ·Sai‐Hong Ignatius Ou, Joanne Xiu, Misako Nagasaka, Bing Xia, Shannon Zhang, Qing Zhang, Jeffrey Swensen, David Spetzler, W. Michael Korn, Viola W. Zhu, Stephen V. Liu	6
16	A Case of Myeloid Sarcoma following Allogeneic HSCT Presenting as Localized Hip Pain 2019 ·SHILAP Revista de lepidopterología ·Shannon Zhang, (unknown), (unknown), (unknown)	2
17	Combination immunotherapy with TLR agonists and checkpoint inhibitors suppresses head and neck cancer 2017 ·JCI Insight ·Fumi Sato-Kaneko, Shiyin Yao, (unknown), Shannon Zhang, Tadashi Hosoya, Megan M. Kaneda, Judith A. Varner, Minya Pu, Karen Messer, Cristiana Guiducci, Robert L. Coffman, Kazutaka Kitaura, Takaji Matsutani, Ryuji Suzuki, Dennis A. Carson, Tomoko Hayashi, Ezra E.W. Cohen	230
18	Evaluating Acquisition of Knowledge about Infertility Using a Whiteboard Video 2016 ·Journal of Obstetrics and Gynaecology Canada ·(unknown), (unknown), Shannon Zhang, (unknown), Philip M. Hahn, Robert L. Reid	13
19	Neuregulin-activated ERBB4 induces the SREBP-2 cholesterol biosynthetic pathway and increases low-density lipoprotein uptake 2015 ·Science Signaling ·Jonathan W. Haskins, Shannon Zhang, Robert E. Means, Joanne K. Kelleher, Gary W. Cline, Alberto Canfrán‐Duque, Yajaira Suárez, David F. Stern	33
20	Enhancement of the Immunostimulatory Activity of a TLR7 Ligand by Conjugation to Polysaccharides 2015 ·Bioconjugate Chemistry ·Hiroyuki Shinchi, Brian Crain, Shiyin Yao, Michael Chan, Shannon Zhang, (unknown), Yasuo Suda, Tomoko Hayashi, Howard B. Cottam, Dennis A. Carson	36

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact